This is the authors' abstract. We don't add key points for this paper.
An organocatalytic conspiracy: Organocatalysis and an organocatalytic antibody conspire to create a novel HIV-1 entry inhibitor. A D-proline catalyzed aldol reaction was used to set the key stereochemistry of CCR5 inhibitor, Aplaviroc, prior to introduction as a targeting unit for chemical programming of aldolase antibody 38C2. The resulting antibody conjugate was a potent inhibitor of HIV-1 and SIV entry.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Gavrilyuk et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: